雄附方治疗类风湿关节炎间质性肺病的临床观察

Treatment of rheumatoid arthritis-related interstitial lung disease with Xiongfu Prescription

  • 摘要: 目的 观察雄附方治疗类风湿关节炎间质性肺病的临床疗效。 方法 选择诊断明确的99例类风湿性关节炎间质性肺病患者,随机分为治疗组49例、对照组50例;二组均给予中草药基础方(随证加减)汤剂口服,治疗组加服雄附方(雄黄0.08g,制白附子0.96g,僵蚕0.96g)。 结果 治疗组显效(PR)8例,有效(CR)32例,无效(NR)9例,总有效率81.6%。对照组显效3例,有效23例,无效24例,总有效率52.0%。二组总有效率经统计学比较P<0.01。 结论 雄附方治疗类风湿关节炎间质性肺病疗效明确可靠。

     

    Abstract: Objective To observe the clinical effect of Xiongfu Prescription(realgar and prepared aconite root) on rheumatoid arthritis-related interstitial lung disease(RA-ILD). Methods Ninety-nine patients with established RA-ILD were randomly divided into treatment group(n=49) and control group(n=50).Patients in control group were treated with herbal decoction,while those in treatment group were treated with combined herbal decoction and Xiongfu Prescription(0.08g realgar,0.96g prepared aconite root,and 0.96g white-stiff silkworm). Results The combined herbal decoction and Xiongfu Prescription was significantly effective for 8 patients,effective for 32 patients,and ineffective for 9 patients in the treatment group,with a total effective rate of 81.6%,while the herbal decoction was significantly effective for 3 patients,effective for 23 patients,and ineffective for 24 patients in the control group,with a total effective rate of 52.0%(P<0.01). Conclusion Xiongfu Prescription has a significant and reliable effect on RA-ILD.

     

/

返回文章
返回